5311 - 5320 of 6256 Results
Title
Year
-
OPENTitle: The relationship between obsessive‐compulsive symptoms and PARKIN genotype: The CORE‐PD studyJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 2Start Page: 278End Page: 283Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26065Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4318772Citation Count: 19
- Disclosure of research results in genetic studies of Parkinson's disease caused byLRRK2mutations2015OPENTitle: Disclosure of research results in genetic studies of Parkinson's disease caused byLRRK2mutationsJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 904End Page: 908Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26250Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4478096Citation Count: 12
-
OPENTitle: Balancing the basal ganglia circuitry: A possible new role for dopamine D2 receptors in health and diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 895End Page: 903Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26282Best OA location URL: https://europepmc.org/articles/pmc4913465?pdf=renderCitation Count: 47
- Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene2015OPENTitle: Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 981End Page: 986Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26213Best OA location URL: http://doi.org/10.1002/mds.26213Citation Count: 61
-
OPENTitle: Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD)Journal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 11Start Page: 1530End Page: 1537Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23151Best OA location URL: https://europepmc.org/articles/pmc4775095?pdf=renderCitation Count: 25
-
OPENTitle: Peptidoglycan recognition protein genes and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1171End Page: 1180Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25895Best OA location URL: http://doi.org/10.1002/mds.25895Citation Count: 48
-
OPENTitle: Olfactory dysfunction in Parkinson's disease: Positive effect of cigarette smokingJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 6Start Page: 859End Page: 862Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26126Best OA location URL: http://doi.org/10.1002/mds.26126Citation Count: 34
-
OPENTitle: Isolation and characterization of antibody fragments selective for toxic oligomeric tauJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 3Start Page: 1342End Page: 1355Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.12.002Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.12.002Citation Count: 27
-
OPENTitle: MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trialsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 37Issue #:Start Page: 26End Page: 37Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2015.09.018Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0197458015004753Citation Count: 46
-
OPENTitle: Sequencing of the GBA coactivator, Saposin C, in Parkinson diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 72Issue #:Start Page: 187.e1End Page: 187.e3Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.06.034Citation Count: 22